Equity

Share capital$-$preference, $6\%$ cumulative, $50$ par value, $106,000$ shares authorized, $26,500$ shares issued and outstanding

Share capital$-$ordinary, $1$ par, $9,900,000$ shares authorized, $990,000$ shares issued and outstanding

Share premium$-$ordinary $($includes any amounts for options and conversions$)$

Retained earnings

Total equity

Long$-$term debt

Notes payable, $10\%$

Convertible bonds payable

$10\%$ bonds payable

For the fiscal year ended June $30,2022,$ calculate the following for Vaughn Pharmaceutical Industries. $($Round answers to $2$ decimal

places, e$.$g$.2\mathrm{.}45.)$

$($a$)$ Basic earnings per share.

Basic earnings per share $,$

$($b$)$ Diluted earnings per share.

Diluted earnings per share $$